Kathleen Moore to Kaplan-Meier Estimate
This is a "connection" page, showing publications Kathleen Moore has written about Kaplan-Meier Estimate.
Connection Strength
0.183
-
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. N Engl J Med. 2018 12 27; 379(26):2495-2505.
Score: 0.147
-
Evaluation of Prexasertib, a Checkpoint Kinase 1 Inhibitor, in a Phase Ib Study of Patients with Squamous Cell Carcinoma. Clin Cancer Res. 2018 07 15; 24(14):3263-3272.
Score: 0.035